检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Efficacy of panitumumab in patients with left-sided disease, MSS/MSI-L, and RAS/BRAF WT: A biomarker study of the phase III PARADIGM trial.

Kentaro Yamazaki,Kei Muro,Jun Watanabe,Kohei Shitara,Hisatsugu Ohori,Manabu Shiozawa,Hirofumi Yasui,Eiji Oki,Takeo Sato,Takeshi Naito,Yoshito Komatsu,Takeshi Kato,Junpei Soeda,Kouji Yamamoto,Riu Yamashita,Kiwamu Akagi,Atsushi Ochiai,Hiroyuki Uetake,Katsuya Tsuchihara,Takayuki Yoshino

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览8
暂无评分
关键词
panitumumab,biomarker study,phase iii paradigm trial,left-sided
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要